News

STAT5hOpinion
Steve Forbes: CMS must cover FDA-approved medical devices and treatments
CMS often withholds coverage for reimbursement, disrupting the natural flow of the market and hindering access to proven ...
FDA Chief Says He Wants Gene Therapy Head Prasad to Return
US Food and Drug Administration Commissioner Marty Makary said he’s trying to persuade Vinay Prasad, the agency’s former head ...
FDA chief says NIH ‘brewed up a virus that killed 20 million people’
Commissioner Marty Makary again promoted a conspiracy theory about the origins of the COVID-19 pandemic on Wednesday, ...
FDA commissioner predicts ‘record’ drug approvals this year
FDA Commissioner Marty Makary said the FDA’s review process will not slow down despite layoffs at the Department of Health ...
FDA's Makary wants to increase drug access, reduce 'addictive' foods
FDA Commissioner Marty Makary spoke with Yahoo Finance about solving the food crisis, obesity crisis, and restoring trust in ...
BioSpace5d
After Prasad’s Ouster, Makary Looks for Better Drug, Biologic Alignment at FDA
The FDA has denied that it plans to combine the Center for Drug Evaluation and Research and Center for Biologics Evaluation ...
The FDA Boss on the Agency’s MAHA Makeover
Dr. Marty Makary has criticized the Food and Drug Administration for being "captured" by Big Food and Big Pharma. Now, the ...
CNBC host rips Trump adviser unaware of outstanding issue: ‘Can you look into it?!’
While interviewing Makary on “Squawk Box” early Wednesday, Kernen pointed to a new proposal from Environmental Protection ...
News Nation on MSN6d
FDA cracking down on 7-OH to avoid epidemic: Commissioner
7-OH, formally known as 7-Hydroxymitragynine, is banned in China; however, Makary found that in the Biden administration, the ...
Houston Public Media5d
An FDA panel spread misinformation about SSRI use in pregnancy, alarming doctors
A panel organized by the FDA cast doubts on the safety of antidepressants during pregnancy — drawing ire from doctors who say ...
Why Vinay Prasad Had to Go at FDA
The gene therapy chief wanted to block fast-track drug approvals.